Passive dual immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta maximally ameliorates acute aminonucleoside nephrosis.
Rats receiving a single dose (10 mg/100 g) of aminonucleoside of puromycin (PAN) develop heavy proteinuria and acute interstitial nephritis (AIN). Whole isolated glomeruli from rats injected with PAN secreted both TNF-alpha and IL-1 beta cytokines. TNF-alpha secretion was first and maximally detected on day 3, whereas IL-beta activity was found on day 7, when rats were heavily proteinuric and AIN developed. In vivo treatment with either anti-TNF-alpha or anti-IL-1 beta antibodies produced a drastic and simultaneous reduction in both levels of proteinuria and intensity of interstitial cell infiltrate. These effects improved when both antibodies were administered together. Our studies demonstrate the effectiveness of immunosuppressive therapy against these two cytokines in rats with PAN-induced nephrosis.
Martín
A
A
Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.
Molina
A
A
Bricio
T
T
Mampaso
F
F
D000818:Animals; D007116:Immunization, Passive / Q000379:methods; D007124:Immunoenzyme Techniques; D007375:Interleukin-1 / Q000276:immunology* / Q000378:metabolism; D007678:Kidney Glomerulus / Q000276:immunology; D009395:Nephritis, Interstitial / Q000209:etiology / Q000628:therapy; D009401:Nephrosis / Q000139:chemically induced / Q000150:complications / Q000628:therapy*; D011507:Proteinuria / Q000209:etiology / Q000628:therapy; D011692:Puromycin Aminonucleoside; D051381:Rats; D017207:Rats, Sprague-Dawley; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology* / Q000378:metabolism
D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D011692:Puromycin Aminonucleoside